The research company Curasight reduces its convertible debt after Fenja Capital chose to partially convert its loan into 429,363 new shares, corresponding to approximately 4.3 million Danish kroner. All newly issued shares have subsequently been sold in a block transaction to a consortium of long-term investors for a total of approximately 6.8 million Danish kroner.The number of shares in the company increases to 48,352,204, resulting in a dilution effect of approximately 0.9 percent. "We see it as positive that Fenja Capital has chosen to convert into shares, as it reduces Curasight's debt and extends our financial runway," says CEO Ulrich Krasilnikoff. Sedermera Corporate Finance was bookrunner.